RSS   Newsletter   Contact   Advertise with us

Anthera Pharmaceuticals announces personnel changes

Staff writer | Hayward, Ca., USA | April 2, 2014
Steven EngleApril 2, 2014, Hayward, Ca., USA - Anthera Pharmaceuticals, Inc., a biopharmaceutical company, announced the appointment of Steven Engle to the board and the departure of James Healy from its board of directors.
Mr. Engle has served as the Chief Executive Officer of Averigon Consulting, an advisory firm to the life sciences industry, since 2011. Prior to Averigon, he was the Chairman, Chief Executive Officer and President of Xoma Corporation, a public biotechnology company.

Prior to Xoma Corporation, Mr. Engle was Chairman and Chief Executive Officer of La Jolla Pharmaceutical Company.

Prior to La Jolla Pharmaceuticals Company, Mr. Engle served as the Vice President of Marketing for Cygnus, a drug delivery company, where he helped gain FDA approval of and launch Nicotrol for smoking cessation.

Mr. Engle is a member of the Board of Directors of BayBio and has served on the board of the Lupus Foundation of America. Mr. Engle holds a MSEE and BSEE, each from the University of Texas at Austin.

Dr. James Healy has resigned his position as a Director effective March 25th, 2014. Dr. Healy, General Partner of Sofinnova Ventures, joined Anthera's board in 2006.